Bifogade filer
PDF
Kurs & Likviditet
Kalender
| 2024-10-24 | Kvartalsrapport 2024-Q3 |
| 2024-07-18 | Kvartalsrapport 2024-Q2 |
| 2024-06-28 | Ordinarie utdelning HNSA 0.00 SEK |
| 2024-06-27 | Årsstämma 2024 |
| 2024-04-18 | Kvartalsrapport 2024-Q1 |
| 2024-02-02 | Bokslutskommuniké 2023 |
| 2023-10-26 | Kvartalsrapport 2023-Q3 |
| 2023-07-20 | Kvartalsrapport 2023-Q2 |
| 2023-06-15 | Ordinarie utdelning HNSA 0.00 SEK |
| 2023-06-14 | Årsstämma 2023 |
| 2023-04-20 | Kvartalsrapport 2023-Q1 |
| 2023-02-02 | Bokslutskommuniké 2022 |
| 2022-10-20 | Kvartalsrapport 2022-Q3 |
| 2022-07-19 | Kvartalsrapport 2022-Q2 |
| 2022-06-17 | Ordinarie utdelning HNSA 0.00 SEK |
| 2022-06-16 | Årsstämma 2022 |
| 2022-04-21 | Kvartalsrapport 2022-Q1 |
| 2022-02-03 | Bokslutskommuniké 2021 |
| 2021-10-21 | Kvartalsrapport 2021-Q3 |
| 2021-07-15 | Kvartalsrapport 2021-Q2 |
| 2021-05-14 | Ordinarie utdelning HNSA 0.00 SEK |
| 2021-05-12 | Årsstämma 2021 |
| 2021-04-22 | Kvartalsrapport 2021-Q1 |
| 2021-02-04 | Bokslutskommuniké 2020 |
| 2020-10-22 | Kvartalsrapport 2020-Q3 |
| 2020-07-16 | Kvartalsrapport 2020-Q2 |
| 2020-06-24 | Ordinarie utdelning HNSA 0.00 SEK |
| 2020-06-23 | Årsstämma 2020 |
| 2020-04-28 | Kvartalsrapport 2020-Q1 |
| 2020-02-06 | Bokslutskommuniké 2019 |
| 2019-10-31 | Kvartalsrapport 2019-Q3 |
| 2019-07-18 | Kvartalsrapport 2019-Q2 |
| 2019-05-23 | Ordinarie utdelning HNSA 0.00 SEK |
| 2019-05-22 | Årsstämma 2019 |
| 2019-04-29 | Kvartalsrapport 2019-Q1 |
| 2019-02-08 | Bokslutskommuniké 2018 |
| 2018-11-01 | Kvartalsrapport 2018-Q3 |
| 2018-07-19 | Kvartalsrapport 2018-Q2 |
| 2018-05-30 | Ordinarie utdelning HNSA 0.00 SEK |
| 2018-05-29 | Årsstämma 2018 |
| 2018-04-25 | Kvartalsrapport 2018-Q1 |
| 2018-02-14 | Bokslutskommuniké 2017 |
| 2017-12-22 | Extra Bolagsstämma 2017 |
| 2017-11-14 | Kvartalsrapport 2017-Q3 |
| 2017-07-20 | Kvartalsrapport 2017-Q2 |
| 2017-05-24 | Ordinarie utdelning HNSA 0.00 SEK |
| 2017-05-23 | Årsstämma 2017 |
| 2017-04-26 | Kvartalsrapport 2017-Q1 |
| 2017-02-15 | Bokslutskommuniké 2016 |
| 2016-11-21 | Extra Bolagsstämma 2016 |
| 2016-11-09 | Kvartalsrapport 2016-Q3 |
| 2016-07-21 | Kvartalsrapport 2016-Q2 |
| 2016-05-11 | Årsstämma 2016 |
| 2016-04-28 | Ordinarie utdelning HNSA 0.00 SEK |
| 2016-04-27 | Kvartalsrapport 2016-Q1 |
| 2016-02-18 | Bokslutskommuniké 2015 |
| 2015-10-28 | Kvartalsrapport 2015-Q3 |
| 2015-08-25 | Kvartalsrapport 2015-Q2 |
| 2015-04-17 | Ordinarie utdelning HNSA 0.00 SEK |
| 2015-04-16 | Årsstämma 2015 |
| 2015-04-16 | Kvartalsrapport 2015-Q1 |
| 2015-02-05 | Bokslutskommuniké 2014 |
| 2014-07-25 | Kvartalsrapport 2014-Q2 |
| 2014-06-04 | Ordinarie utdelning HNSA 0.00 SEK |
| 2014-06-03 | Årsstämma 2014 |
| 2014-03-05 | Extra Bolagsstämma 2014 |
| 2014-02-05 | Bokslutskommuniké 2013 |
| 2013-07-25 | Kvartalsrapport 2013-Q2 |
| 2013-05-07 | Ordinarie utdelning HNSA 0.00 SEK |
| 2013-05-06 | Årsstämma 2013 |
| 2013-02-07 | Bokslutskommuniké 2012 |
| 2012-09-28 | Kapitalmarknadsdag 2012 |
| 2012-07-26 | Kvartalsrapport 2012-Q2 |
| 2012-05-14 | Årsstämma 2012 |
| 2012-02-09 | Bokslutskommuniké 2011 |
| 2012-01-09 | Extra Bolagsstämma 2011 |
| 2011-07-28 | Kvartalsrapport 2011-Q2 |
| 2011-05-12 | Årsstämma 2011 |
| 2011-05-06 | Ordinarie utdelning HNSA 0.00 SEK |
| 2010-04-30 | Ordinarie utdelning HNSA 0.00 SEK |
| 2010-02-10 | Bokslutskommuniké 2009 |
| 2009-07-30 | Kvartalsrapport 2009-Q1 |
| 2009-05-12 | Kvartalsrapport 2009-Q2 |
| 2009-04-30 | Ordinarie utdelning HNSA 0.00 SEK |
| 2009-04-29 | Årsstämma 1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Mid Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Lund, Sweden, September 30, 2022. Hansa Biopharma AB "Hansa" or the "Company", (Nasdaq Stockholm: HNSA), the pioneer enzyme technology for rare immunological conditions, today announces that the Company's registered share capital and number of outstanding shares and votes have increased during the month of September 2022.
As previously announced on 8 September 2022, Hansa Biopharma's board of directors resolved to issue 850,769 class C shares, by virtue of the authorizations by the annual general meeting held on 30 June 2022. The class C shares do not entitle to dividends and each share entitles to 1/10 voting right.
The purpose of the issue and repurchase was to ensure delivery of shares to employees and to secure potential social contributions arising as a result of the Company's incentive programs in accordance with the resolutions from the annual general meeting held on 30 June 2022.
As of today, the total number of registered and outstanding shares of the Company amounts to 47,186,130, whereof 44,588,118 are ordinary shares and 2,598,012 are class C shares. As of today, the number of votes in the Company amounts to 44,847,919.2, and the registered share capital amounts to SEK 47,186,130.
This information is information that Hansa Biopharma AB is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication on September 30, 2022, at 17:00 CEST
--ENDS-
Klaus Sindahl, Head of Investor Relations
Hansa Biopharma
Mobile: +46 (0) 709-298 269
E-mail: klaus.sindahl@hansabiopharma.com